サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1404756

リアルワールドエビデンス（RWE）ソリューションの市場規模、シェア、動向分析レポート：コンポーネント別、用途別、最終用途別、地域別、セグメント別予測（2024年～2030年）

Real World Evidence Solutions Market Size, Share & Trends Analysis Report By Component (Services, Data Sets), By Application, By End-use, By Region, And Segment Forecasts, 2024 - 2030
出版日: | 発行: Grand View Research | ページ情報: 英文 200 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=155.76円
リアルワールドエビデンス（RWE）ソリューションの市場規模、シェア、動向分析レポート：コンポーネント別、用途別、最終用途別、地域別、セグメント別予測（2024年～2030年）
出版日: 2023年11月24日
発行: Grand View Research
ページ情報: 英文 200 Pages
納期: 2～10営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

リアルワールドエビデンス（RWE）ソリューション市場の成長と動向：

世界のリアルワールドエビデンス（RWE）ソリューションの市場規模は、2024年 ～2030年にCAGR8.4％を記録し、2030年までに46億米ドルに達すると予測されています。

市場を牽引する主な要因には、有利な政府規制や、量から価値ベースのケアへのシフトなどがあります。さらに、慢性疾患の有病率の増加が市場成長にプラスの影響を与えると予測されています。

パンデミックの間、RWEソリューション市場の企業はCOVID-19の蔓延を抑制するソリューションの提供に注力しました。例えば、IBMはSalesforceと協力してデジタルヘルスパスを構築し、ワクチン接種状況、体温チェック、COVID-19検査結果などのデータを組み込んで、組織の安全な再開を支援しました。また、ServiceNowとWatson AIOpsで提携し、顧客のIT運用の自動化とリスク削減を支援することで、ServiceNowが変革的な人工知能でリーダーシップを取り続けることを支援しました。

PerkinElmerによると、リアルワールドエビデンス（RWE）ソリューションは、米国のヘルスケア業界だけでもトップダウンで約3,000億～5,000億米ドルのビジネスチャンスをもたらすとのことです。さらに、多くのライフサイエンス企業は、選択されたRWEのケーススタディからその場その場の価値を確認し、約1億米ドルのボトムアップ効果を実証しています。したがって、ある企業が10億米ドルのリアルワールドエビデンスの価値を獲得すれば、最終的には数百億米ドルを超えるヘルスケアの改善を生み出すことになります。これは、今後数年間の市場成長を後押しすると予想されます。

RWEソリューションの市場開拓と利用は、北米と欧州の新興国市場でより進んでいますが、これは法律、政府、その他の規制機関による支援イニシアチブのためです。例えば、2021年10月、FDAはAetion Evidence Platformを選択し、RWEを使用してCOVID-19介入を分析し、規制科学とイノベーションをさらに進めました。規制機関によるイニシアチブは、市販後の安全性モニタリングから、臨床試験デザインや観察研究、保険適用決定の立証などの他の用途へのRWEの拡大を支援しています。

市場競争力を維持するため、市場企業は買収、合併、提携、製品発売など多くの戦略的イニシアティブに投資しています。例えば、Verana Healthは2023年6月、臨床試験施設ソリューションの新機軸であるVeraSiteを発表しました。

リアルワールドエビデンス（RWE）ソリューション市場のレポートハイライト

  • 政府の好意的な取り組みと、量から価値ベースのケアへのシフトが市場成長を押し上げると予想されます。
  • サービスコンポーネント分野は、予測期間中の需要増加により、2023年に57.6%の最大市場シェアを占めました。
  • 医薬品開発・承認用途セグメントは、製薬会社におけるこの用途へのRWEソリューションの採用が増加しているため、2023年に28.7%の収益シェアで市場を独占しました。
  • ヘルスケア支払者最終用途セグメントは、医薬品と医療機器の安全性に関する支払者の意識の高まりにより、予測期間中に最も速いCAGRで拡大すると予測されています。
  • 北米は、同地域に大手企業が存在することから、2023年の売上高シェアは43.5%で世界市場をリードしています。アジア太平洋は、2024年～2030年に最も急成長する地域市場になると予想されますが、これは同地域に開発業務受託機関が存在するためです。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

    • 市場の見通し
    • セグメントの見通し
    • 競合考察

第3章 リアルワールドエビデンス（RWE）ソリューション市場の変数、動向、範囲

      • 市場系統の見通し
    • 親市場の見通し
    • 付随市場の見通し
      • 普及と成長見通しマッピング
      • 市場力学
    • 市場促進要因分析
    • 市場抑制要因分析
    • 市場機会分析
    • 市場課題分析
      • リアルワールドエビデンス（RWE）ソリューション：市場分析ツール
    • 業界分析：ポーターのファイブフォース分析
    • PESTLE分析
  • 規制の枠組み
  • 価格モデル分析
    • 使用量ごとの支払う
    • 患者ごとの支払い記録
    • 年間会費

第4章 COVID-19がリアルワールドエビデンス（RWE）ソリューション市場に与える影響

  • 病気の有病率の分析
  • 現在および将来の影響分析
  • COVID-19の市場参入企業への影響
  • 機会分析

第5章 リアルワールドエビデンス（RWE）ソリューション市場：コンポーネントの推定と予測（～2030年）

  • 定義と範囲
  • コンポーネントタイプの市場シェア分析（2023年・2030年）
  • セグメントダッシュボード
  • 世界のリアルワールドエビデンス（RWE）ソリューション市場：コンポーネント別（2023年～2030年）
  • 市場規模、予測、動向分析（2023年～2030年）
    • サービス
    • データセット

第6章 リアルワールドエビデンス（RWE）ソリューション市場：用途の推定と予測（～2030年）

  • 定義と範囲
  • 用途の市場シェア分析（2023年・2030年）
  • セグメントダッシュボード
  • 世界のリアルワールドエビデンス（RWE）ソリューション市場：用途別（2023年～2030年）
  • 市場規模、予測、動向分析（2023年～2030年）
    • 医薬品の開発と承認
    • 医療機器の開発と承認
    • 償還/補償および規制上の意思決定
    • 市販後の安全性と有害事象のモニタリング

第7章 リアルワールドエビデンス（RWE）ソリューション市場：最終用途の推定と予測（～2030年）

  • 定義と範囲
  • 最終用途の市場シェア分析（2023年・2030年）
  • セグメントダッシュボード
  • 世界のリアルワールドエビデンス（RWE）ソリューション市場：最終用途別（2023年～2030年）
  • 市場規模、予測、動向分析（2023年～2030年）
    • ヘルスケア企業
    • ヘルスケア支払者
    • ヘルスケア提供者
    • その他

第8章 リアルワールドエビデンス（RWE）ソリューション市場：地域推定・動向分析：コンポーネント別、用途別、最終用途別

  • 定義と範囲
  • 地域市場シェア分析（2023年・2030年）
  • 北米
    • 北米のリアルワールドエビデンス（RWE）ソリューション市場（2018年～2030年）
  • 欧州
    • 欧州のリアルワールドエビデンス（RWE）ソリューション市場（2018年～2030年）
  • アジア太平洋
    • アジア太平洋のリアルワールドエビデンス（RWE）ソリューション市場（2018年～2030年）
  • ラテンアメリカ
    • ラテンアメリカのリアルワールドエビデンス（RWE）ソリューション市場（2018年～2030年）
  • 中東・アフリカ
    • 中東・アフリカのリアルワールドエビデンス（RWE）ソリューション市場（2018年～2030年）

第9章 リアルワールドエビデンス（RWE）ソリューション市場：競合分析

  • 企業の市場シェア/ポジション分析
  • ヒートマップ分析
  • 主要企業一覧

第10章 企業プロファイル

  • IQVIA
    • 会社概要
    • 財務実績
    • 製品のベンチマーク
    • 戦略的取り組み
  • IBM
    • 会社概要
    • 財務実績
    • 製品のベンチマーク
    • 戦略的取り組み
  • PPD Inc.
    • 会社概要
    • 財務実績
    • 製品のベンチマーク
    • 戦略的取り組み
  • Parexel International Corporation
    • 会社概要
    • 財務実績
    • 製品のベンチマーク
    • 戦略的取り組み
  • PerkinElmer Inc.
    • 会社概要
    • 財務実績
    • 製品のベンチマーク
    • 戦略的取り組み
  • Icon Plc
    • 会社概要
    • 財務実績
    • 製品のベンチマーク
    • 戦略的取り組み
  • Oracle
    • 会社概要
    • 財務実績
    • 製品のベンチマーク
    • 戦略的取り組み
  • Syneos Health
    • 会社概要
    • 財務実績
    • 製品のベンチマーク
    • 戦略的取り組み
  • Cegedim Health Data
    • 会社概要
    • 財務実績
    • 製品のベンチマーク
    • 戦略的取り組み
  • Medpace
    • 会社概要
    • 財務実績
    • 製品のベンチマーク
    • 戦略的取り組み
図表

List of Tables

  • Table 1 List of primary sources
  • Table 2 List of secondary sources
  • Table 3 North America Real world Evidence Solutions market, by Component, 2018 - 2030 (USD Million)
  • Table 4 North America Real world Evidence Solutions data sets market, by type, 2018 - 2030 (USD Million)
  • Table 5 North America Real world Evidence Solutions market, by applications, 2018 - 2030 (USD Million)
  • Table 6 North America Real world Evidence Solutions market, by end-use, 2018 - 2030 (USD Million)
  • Table 7 U.S. Real world Evidence Solutions market, by Component, 2018 - 2030 (USD Million)
  • Table 8 U.S. Real world Evidence Solutions data sets market, by type, 2018 - 2030 (USD Million)
  • Table 9 U.S. Real world Evidence Solutions market, by applications, 2018 - 2030 (USD Million)
  • Table 10 U.S. Real world Evidence Solutions market, by end-use, 2018 - 2030 (USD Million)
  • Table 11 Canada Real world Evidence Solutions market, by Component, 2018 - 2030 (USD Million)
  • Table 12 Canada Real world Evidence Solutions data sets market, by type, 2018 - 2030 (USD Million)
  • Table 13 Canada Real world Evidence Solutions market, by applications, 2018 - 2030 (USD Million)
  • Table 14 Canada Real world Evidence Solutions market, by end-use, 2018 - 2030 (USD Million)
  • Table 15 Europe Real world Evidence Solutions market, by Component, 2018 - 2030 (USD Million)
  • Table 16 Europe Real world Evidence Solutions data sets market, by type, 2018 - 2030 (USD Million)
  • Table 17 Europe Real world Evidence Solutions market, by applications, 2018 - 2030 (USD Million)
  • Table 18 Europe Real world Evidence Solutions market, by end-use, 2018 - 2030 (USD Million)
  • Table 19 UK Real world Evidence Solutions market, by Component, 2018 - 2030 (USD Million)
  • Table 20 UK Real world Evidence Solutions data sets market, by type, 2018 - 2030 (USD Million)
  • Table 21 UK Real world Evidence Solutions market, by applications, 2018 - 2030 (USD Million)
  • Table 22 UK Real world Evidence Solutions market, by end-use, 2018 - 2030 (USD Million)
  • Table 23 Germany Real world Evidence Solutions market, by Component, 2018 - 2030 (USD Million)
  • Table 24 Germany Real world Evidence Solutions data sets market, by type, 2018 - 2030 (USD Million)
  • Table 25 Germany Real world Evidence Solutions market, by applications, 2018 - 2030 (USD Million)
  • Table 26 Germany Real world Evidence Solutions market, by end-use, 2018 - 2030 (USD Million)
  • Table 27 France Real world Evidence Solutions market, by Component, 2018 - 2030 (USD Million)
  • Table 28 France Real world Evidence Solutions data sets market, by type, 2018 - 2030 (USD Million)
  • Table 29 France Real world Evidence Solutions market, by applications, 2018 - 2030 (USD Million)
  • Table 30 France Real world Evidence Solutions market, by end-use, 2018 - 2030 (USD Million)
  • Table 31 Italy Real world Evidence Solutions market, by Component, 2018 - 2030 (USD Million)
  • Table 32 Italy Real world Evidence Solutions data sets market, by type, 2018 - 2030 (USD Million)
  • Table 33 Italy Real world Evidence Solutions market, by applications, 2018 - 2030 (USD Million)
  • Table 34 Italy Real world Evidence Solutions market, by end-use, 2018 - 2030 (USD Million)
  • Table 35 Spain Real world Evidence Solutions market, by Component, 2018 - 2030 (USD Million)
  • Table 36 Spain Real world Evidence Solutions data sets market, by type, 2018 - 2030 (USD Million)
  • Table 37 Spain Real world Evidence Solutions market, by applications, 2018 - 2030 (USD Million)
  • Table 38 Spain Real world Evidence Solutions market, by end-use, 2018 - 2030 (USD Million)
  • Table 39 Asia Pacific Real world Evidence Solutions market, by Component, 2018 - 2030 (USD Million)
  • Table 40 Asia Pacific Real world Evidence Solutions data sets market, by type, 2018 - 2030 (USD Million)
  • Table 41 Asia Pacific Real world Evidence Solutions market, by applications, 2018 - 2030 (USD Million)
  • Table 42 Asia Pacific Real world Evidence Solutions market, by end-use, 2018 - 2030 (USD Million)
  • Table 43 Japan Real world Evidence Solutions market, by Component, 2018 - 2030 (USD Million)
  • Table 44 Japan Real world Evidence Solutions data sets market, by type, 2018 - 2030 (USD Million)
  • Table 45 Japan Real world Evidence Solutions market, by applications, 2018 - 2030 (USD Million)
  • Table 46 Japan Real world Evidence Solutions market, by end-use, 2018 - 2030 (USD Million)
  • Table 47 China Real world Evidence Solutions market, by Component, 2018 - 2030 (USD Million)
  • Table 48 China Real world Evidence Solutions data sets market, by type, 2018 - 2030 (USD Million)
  • Table 49 China Real world Evidence Solutions market, by applications, 2018 - 2030 (USD Million)
  • Table 50 China Real world Evidence Solutions market, by end-use, 2018 - 2030 (USD Million)
  • Table 51 India Real world Evidence Solutions market, by Component, 2018 - 2030 (USD Million)
  • Table 52 India Real world Evidence Solutions data sets market, by type, 2018 - 2030 (USD Million)
  • Table 53 India Real world Evidence Solutions market, by applications, 2018 - 2030 (USD Million)
  • Table 54 India Real world Evidence Solutions market, by end-use, 2018 - 2030 (USD Million)
  • Table 55 Australia Real world Evidence Solutions market, by Component, 2018 - 2030 (USD Million)
  • Table 56 Australia Real world Evidence Solutions data sets market, by type, 2018 - 2030 (USD Million)
  • Table 57 Australia Real world Evidence Solutions market, by applications, 2018 - 2030 (USD Million)
  • Table 58 Australia Real world Evidence Solutions market, by end-use, 2018 - 2030 (USD Million)
  • Table 59 South Korea Real world Evidence Solutions market, by Component, 2018 - 2030 (USD Million)
  • Table 60 South Korea Real world Evidence Solutions data sets market, by type, 2018 - 2030 (USD Million)
  • Table 61 South Korea Real world Evidence Solutions market, by applications, 2018 - 2030 (USD Million)
  • Table 62 South Korea Real world Evidence Solutions market, by end-use, 2018 - 2030 (USD Million)
  • Table 63 Latin America Real world Evidence Solutions market, by Component, 2018 - 2030 (USD Million)
  • Table 64 Latin America Real world Evidence Solutions data sets market, by type, 2018 - 2030 (USD Million)
  • Table 65 Latin America Real world Evidence Solutions market, by applications, 2018 - 2030 (USD Million)
  • Table 66 Latin America Real world Evidence Solutions market, by end-use, 2018 - 2030 (USD Million)
  • Table 67 Brazil Real world Evidence Solutions market, by Component, 2018 - 2030 (USD Million)
  • Table 68 Brazil Real world Evidence Solutions data sets market, by type, 2018 - 2030 (USD Million)
  • Table 69 Brazil Real world Evidence Solutions market, by applications, 2018 - 2030 (USD Million)
  • Table 70 Brazil Real world Evidence Solutions market, by end-use, 2018 - 2030 (USD Million)
  • Table 71 Mexico Real world Evidence Solutions market, by Component, 2018 - 2030 (USD Million)
  • Table 72 Mexico Real world Evidence Solutions data sets market, by type, 2018 - 2030 (USD Million)
  • Table 73 Mexico Real world Evidence Solutions market, by applications, 2018 - 2030 (USD Million)
  • Table 74 Mexico Real world Evidence Solutions market, by end-use, 2018 - 2030 (USD Million)
  • Table 75 Argentina Real world Evidence Solutions market, by Component, 2018 - 2030 (USD Million)
  • Table 76 Argentina Real world Evidence Solutions data sets market, by type, 2018 - 2030 (USD Million)
  • Table 77 Argentina Real world Evidence Solutions market, by applications, 2018 - 2030 (USD Million)
  • Table 78 Argentina Real world Evidence Solutions market, by end-use, 2018 - 2030 (USD Million)
  • Table 79 MEA Real world Evidence Solutions market, by Component, 2018 - 2030 (USD Million)
  • Table 80 MEA Real world Evidence Solutions data sets market, by type, 2018 - 2030 (USD Million)
  • Table 81 MEA Real world Evidence Solutions market, by applications, 2018 - 2030 (USD Million)
  • Table 82 MEA Real world Evidence Solutions market, by end-use, 2018 - 2030 (USD Million)
  • Table 83 South Africa Real world Evidence Solutions market, by Component, 2018 - 2030 (USD Million)
  • Table 84 South Africa Real world Evidence Solutions data sets market, by type, 2018 - 2030 (USD Million)
  • Table 85 South Africa Real world Evidence Solutions market, by applications, 2018 - 2030 (USD Million)
  • Table 86 South Africa Real world Evidence Solutions market, by end-use, 2018 - 2030 (USD Million)
  • Table 87 Saudi Arabia Real world Evidence Solutions market, by Component, 2018 - 2030 (USD Million)
  • Table 88 Saudi Arabia Real world Evidence Solutions data sets market, by type, 2018 - 2030 (USD Million)
  • Table 89 Saudi Arabia Real world Evidence Solutions market, by applications, 2018 - 2030 (USD Million)
  • Table 90 Saudi Arabia Real world Evidence Solutions market, by end-use, 2018 - 2030 (USD Million)
  • Table 91 Israel Real world Evidence Solutions market, by Component, 2018 - 2030 (USD Million)
  • Table 92 Israel Real world Evidence Solutions data sets market, by type, 2018 - 2030 (USD Million)
  • Table 93 Israel Real world Evidence Solutions market, by applications, 2018 - 2030 (USD Million)
  • Table 94 Israel Real world Evidence Solutions market, by end-use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market summary
  • Fig. 2 Market trends & outlook
  • Fig. 3 Market segmentation & scope
  • Fig. 4 Market driver relevance analysis (Current & future impact)
  • Fig. 5 Market restraint relevance analysis (Current & future impact)
  • Fig. 6 Penetration & growth prospect mapping
  • Fig. 7 SWOT Analysis, By Factor (political & legal, economic and technological)
  • Fig. 8 Real world Evidence Solutions: Porter's Analysis
  • Fig. 9 Real world Evidence Solutions market, Component outlook key takeaways
  • Fig. 10 Real world Evidence Solutions market: Component movement analysis
  • Fig. 11 Global Services market, 2018 - 2030 (USD Million)
  • Fig. 12 Global Data Sets market, 2018 - 2030 (USD Million)
  • Fig. 13 Global Clinical Settings Data market, 2018 - 2030 (USD Million)
  • Fig. 14 Global Claims Data market, 2018 - 2030 (USD Million)
  • Fig. 15 Global Pharmacy Data market, 2018 - 2030 (USD Million)
  • Fig. 16 Global Patient-Powered Data market, 2018 - 2030 (USD Million)
  • Fig. 17 Global Pharmacy Data market, 2018 - 2030 (USD Million)
  • Fig. 18 Real world Evidence Solutions market, application outlook key takeaways
  • Fig. 19 Real world Evidence Solutions market: Application movement analysis
  • Fig. 20 Global Drug Development & Approvals market, 2018 - 2030 (USD Million)
  • Fig. 21 Global Medical Device Development & Approvals market, 2018 - 2030 (USD Million)
  • Fig. 22 Global Reimbursement/Coverage & Regulatory Decision Making market, 2018 - 2030 (USD Million)
  • Fig. 23 Global Post Market Safety & Adverse Events Monitoring market, 2018 - 2030 (USD Million)
  • Fig. 24 Real world Evidence Solutions market, End-use outlook key takeaways
  • Fig. 25 Real world Evidence Solutions market: End-use movement analysis
  • Fig. 26 Global Healthcare Companies market, 2018 - 2030 (USD Million)
  • Fig. 27 Global Healthcare Payers market, 2018 - 2030 (USD Million)
  • Fig. 28 Global Healthcare Providers market, 2018 - 2030 (USD Million)
  • Fig. 29 Global others market, 2018 - 2030 (USD Million)
  • Fig. 30 Regional market: Key takeaways
  • Fig. 31 Regional outlook, 2023 & 2030
  • Fig. 32 North America Real world Evidence Solutions market, 2018 - 2030 (USD Million)
  • Fig. 33 U.S. Real world Evidence Solutions market, 2018 - 2030 (USD Million)
  • Fig. 34 Canada Real world Evidence Solutions market, 2018 - 2030 (USD Million)
  • Fig. 35 Europe Real world Evidence Solutions market, 2018 - 2030 (USD Million)
  • Fig. 36 UK Real world Evidence Solutions market, 2018 - 2030 (USD Million)
  • Fig. 37 Germany Real world Evidence Solutions market, 2018 - 2030 (USD Million)
  • Fig. 38 France Real world Evidence Solutions market, 2018 - 2030 (USD Million)
  • Fig. 39 Italy Real world Evidence Solutions market, 2018 - 2030 (USD Million)
  • Fig. 40 Spain Real world Evidence Solutions market, 2018 - 2030 (USD Million)
  • Fig. 41 Asia Pacific Real world Evidence Solutions market, 2018 - 2030 (USD Million)
  • Fig. 42 Japan Real world Evidence Solutions market, 2018 - 2030 (USD Million)
  • Fig. 43 China Real world Evidence Solutions market, 2018 - 2030 (USD Million)
  • Fig. 44 India Real world Evidence Solutions market, 2018 - 2030 (USD Million)
  • Fig. 50 Australia Real world Evidence Solutions market, 2018 - 2030 (USD Million)
  • Fig. 51 South Korea Real world Evidence Solutions market, 2018 - 2030 (USD Million)
  • Fig. 52 Latin America Real world Evidence Solutions market, 2018 - 2030 (USD Million)
  • Fig. 53 Brazil Real world Evidence Solutions market, 2018 - 2030 (USD Million)
  • Fig. 54 Mexico Real world Evidence Solutions market, 2018 - 2030 (USD Million)
  • Fig. 55 Argentina Real world Evidence Solutions market, 2018 - 2030 (USD Million)
  • Fig. 56 MEA Real world Evidence Solutions market, 2018 - 2030 (USD Million)
  • Fig. 57 South Africa Real world Evidence Solutions market, 2018 - 2030 (USD Million)
  • Fig. 58 Saudi Arabia Real world Evidence Solutions market, 2018 - 2030 (USD Million)
  • Fig. 59 Israel Real world Evidence Solutions market, 2018 - 2030 (USD Million)
  • Fig. 60 Strategy framework
  • Fig. 61 Participant categorization
目次
Product Code: GVR-4-68039-808-0

Real World Evidence Solutions Market Growth & Trends:

The global real world evidence solutions market size is expected to reach USD 4.6 billion by 2030, registering a CAGR of 8.4% from 2024 to 2030, according to a new report by Grand View Research, Inc. Key factors driving the market include favorable government regulations and a shift from volume to value-based care. Furthermore, the increasing prevalence of chronic disorders is anticipated to positively influence market growth.

During the pandemic, companies in the RWE solutions market diverted their focus on providing solutions for curbing the spread of COVID-19. For instance, IBM collaborated with Salesforce to build digital health passes, which incorporated data such as vaccine status, temperature checks, and COVID-19 test results to help organizations reopen safely. It also partnered with ServiceNow on Watson AIOps to support it to continue its leadership in transformative artificial intelligence by helping clients automate IT operations and reduce risks.

According to PerkinElmer, real world evidence solutions offer around USD 300 to 500 Billion in top-down opportunity for the U.S. healthcare industry alone. In addition, many life science companies are witnessing ad hoc value from selected RWE case studies and demonstrating around USD 100 million of bottom-up impact. Therefore, if a company captures USD 1 billion in real world evidence value, it ultimately creates more than USD tens of billions in terms of healthcare improvements. This is anticipated to boost market growth over the coming years.

Adoption and usage of RWE solutions are higher in developed markets of North America and Europe owing to supportive initiatives by legal, government, and other regulatory bodies. For instance, in October 2021, FDA selected Aetion Evidence Platform to use RWE to analyze COVID-19 interventions and further regulatory science and innovation. Initiatives by regulatory agencies are supporting the expansion of RWE from post-market safety monitoring to other applications, such as for clinical trial design and observational studies and to substantiate coverage decisions.

Market players are investing in many strategic initiatives, such as acquisitions, mergers, partnerships, and product launches, to maintain a competitive edge in the market. For instance, in June 2023, Verana Health launched VeraSite, a novel solution for clinical trial site solutions.

Real World Evidence Solutions Market Report Highlights:

  • Favorable government initiatives and a shift from volume to value-based care are expected to boost the market growth
  • Services component segment led the largest market share of 57.6% in 2023 owing to its increasing demand over the forecast period
  • Drug development and approvals application segment dominated the market with a revenue share of 28.7% in 2023 owing to the rising adoption of RWE solutions in pharmaceutical companies for this application
  • Healthcare payers end-user segment is anticipated to expand at the fastest CAGR over the forecast period owing to the increasing awareness among payers regarding drug and medical device safety
  • North America led the global market with a revenue share of 43.5% in 2023 owing to the presence of major players in the region. Asia Pacific is expected to be the fastest-growing regional market from 2024 to 2030 owing to the presence of contract research organizations in the region

Table of Contents

Chapter 1 Research Methodology & Scope

  • 1.1 Market Segmentation and Scope
    • 1.1.1 COMPONENT
    • 1.1.2 APPLICATION
    • 1.1.3 END-USE
    • 1.1.4 REGION
    • 1.1.5 Estimates and forecast timeline
  • 1.2 Research methodology
  • 1.3 Information procurement
    • 1.3.1 Purchased database
    • 1.3.2 GVR's internal database
    • 1.3.3 Secondary sources
    • 1.3.4 Primary research
    • 1.3.5 Details of primary research
      • 1.3.5.1 Data for primary interviews in North America
      • 1.3.5.2 Data for primary interviews in Europe
      • 1.3.5.3 Data for primary interviews in Asia Pacific
      • 1.3.5.4 Data for primary interviews in Latin America
      • 1.3.5.5 Data for primary interviews in Middle East & Africa
  • 1.4 Information or Data Analysis
    • 1.4.1 Data analysis models
  • 1.5 Market Formulation & Validation
  • 1.6 Model Details
    • 1.6.1 Commodity Flow Analysis (Model 1)
      • 1.6.1.1 Approach 1: Commodity Flow Approach
      • 1.7List of Secondary Sources
      • 1.8List of Primary Sources
      • 1.9List of Abbreviations
  • 1.10 Objectives
    • 1.10.1 Objective 1
    • 1.10.2 Objective 2
    • 1.10.3 Objective 3
    • 1.10.4 Objective 4

Chapter 2 Executive Summary

      • 2.1Market Outlook
      • 2.2Segment Outlook
      • 2.3Competitive Insights

Chapter 3 Real world Evidence Solutions Market Variables, Trends & Scope

      • 3.1Market Lineage Outlook
    • 3.1.1 Parent market outlook
    • 3.1.2 Ancillary market outlook
      • 3.2Penetration & Growth Prospect Mapping
      • 3.3Market Dynamics
    • 3.3.1 Market driver analysis
      • 3.3.1.1 Favorable government regulations
      • 3.3.1.2 Shift from volume-to-value based care
    • 3.3.2 Market restraint analysis
      • 3.3.2.1 Lack of Standards
    • 3.3.3 Market Opportunity Analysis
    • 3.3.4 Market Challenges Analysis
      • 3.4Real world Evidence Solutions: Market Analysis Tools
    • 3.4.1 Industry analysis - Porter's
      • 3.4.1.1 Bargaining power of buyers:
      • 3.4.1.2 Bargaining power of suppliers:
      • 3.4.1.3 Competitive rivalry:
      • 3.4.1.4 Threat of new entrants:
      • 3.4.1.5 Threat of substitutes:
    • 3.4.2 PESTLE analysis
      • 3.4.2.1 Political landscape
      • 3.4.2.2 Environmental landscape
      • 3.4.2.3 Social landscape
      • 3.4.2.4 Technology landscape
      • 3.4.2.5 Legal landscape
      • 3.4.2.6 Economic landscape
  • 3.5 Regulatory Framework
  • 3.6 Pricing Model Analysis
    • 3.6.1 Pay Per Usage
    • 3.6.2 Pay Per Patient Record
    • 3.6.3 Annual Subscription

Chapter 4 Impact of COVID-19 on Real world Evidence Solutions Market

  • 4.1 Disease Prevalence Analysis
  • 4.2 Current and Future Impact Analysis
  • 4.3 Impact of COVID-19 on Market Players
  • 4.4. Opportunity Analysis

Chapter 5 Real world Evidence Solutions Market: Component Estimates and Forecasts to 2030

  • 5.1 Definition and Scope
  • 5.2 Component Type Market Share Analysis, 2023 & 2030
  • 5.3 Segment Dashboard
  • 5.4 Global Real world Evidence Solutions Market, by Component, 2023 to 2030
  • 5.5 Market Size & Forecasts and Trend Analyses, 2023 to 2030
    • 5.5.1 Services
      • 5.5.1.1 Services market, 2018 - 2030 (USD Million)
    • 5.5.2 Data Sets
      • 5.5.2.1 Data Sets market, 2018 - 2030 (USD Million)
      • 5.5.2.2 Clinical Settings Data
      • 5.5.2.2.1 Clinical Settings Data market, 2018 - 2030 (USD Million)
      • 5.5.2.3 Claims Data
      • 5.5.2.3.1 Claims Data market, 2018 - 2030 (USD Million)
      • 5.5.2.4 Pharmacy Data
      • 5.5.2.4.1 Pharmacy Data market, 2018 - 2030 (USD Million)
      • 5.5.2.5 Patient-Powered Data
      • 5.5.2.5.1 Patient-Powered Data market, 2018 - 2030 (USD Million)

Chapter 6 Real world evidence Solutions Market: Application Estimates and Forecasts to 2030

  • 6.1 Definition and Scope
  • 6.2 Application Market Share Analysis, 2023 & 2030
  • 6.3 Segment Dashboard
  • 6.4 Global Real world evidence Solutions Market, by Application, 2023 to 2030
  • 6.5 Market Size & Forecasts and Trend Analyses, 2023 to 2030
    • 6.5.1 Drug Development & Approvals
      • 6.5.1.1 Drug Development & Approvals market, 2018 - 2030 (USD Million)
    • 6.5.2 Medical Device Development & Approvals
      • 6.5.2.1 Medical Device Development & Approvals market, 2018 - 2030 (USD Million)
    • 6.5.3 Reimbursement/Coverage & Regulatory Decision Making
      • 6.5.3.1 Reimbursement/Coverage & Regulatory Decision Making market, 2018 - 2030 (USD Million)
    • 6.5.4 Post Market Safety & Adverse Events Monitoring
      • 6.5.4.1 Post Market Safety & Adverse Events Monitoring market, 2018 - 2030 (USD Million)

Chapter 7 Real world Evidence Solutions Market: End-use Estimates and Forecasts to 2030

  • 7.1 Definition and Scope
  • 7.2 End-use Market Share Analysis, 2023 & 2030
  • 7.3 Segment Dashboard
  • 7.4 Global Real world Evidence Solutions Market, by end-use, 2023 to 2030
  • 7.5 Market Size & Forecasts and Trend Analyses, 2023 to 2030
    • 7.5.1 Healthcare Companies
      • 7.5.1.1 Healthcare Companies market, 2018 - 2030 (USD Million)
    • 7.5.2 Healthcare Payers
      • 7.5.2.1 Healthcare Payers market, 2018 - 2030 (USD Million)
    • 7.5.3 Healthcare Providers
      • 7.5.3.1 Healthcare Providers market, 2018 - 2030 (USD Million)
    • 7.5.4 Others
      • 7.5.4.1 Others market, 2018 - 2030 (USD Million)

Chapter 8 Real world Evidence Solutions Market: Regional Estimates & Trend Analysis, By Component, Application, End-use

  • 8.1 Definition and Scope
  • 8.2 Regional Market Share Analysis, 2023 & 2030
  • 8.3 North America
    • 8.3.1 North America Real world Evidence Solutions market, 2018 - 2030 (USD Million)
      • 8.3.1.1 U.S.
      • 8.3.1.1.1 U.S. Real world Evidence Solutions market, 2018 - 2030 (USD Million)
      • 8.3.1.2 Canada
      • 8.3.2.1 Canada Real world Evidence Solutions market, 2018 - 2030 (USD Million)
  • 8.4 Europe
    • 8.4.1 Europe Real world Evidence Solutions market, 2018 - 2030 (USD Million)
      • 8.4.1.1 UK
      • 8.4.1.1.UK Real world Evidence Solutions market, 2018 - 2030 (USD Million)
      • 8.4.1.2 Germany
      • 8.4.1.2.1Germany Real world Evidence Solutions market, 2018 - 2030 (USD Million)
      • 8.4.1.3France
      • 8.4.1.3.1 France Real world Evidence Solutions market, 2018 - 2030 (USD Million)
      • 8.4.1.4Italy
      • 8.4.1.4.1 Italy Real world Evidence Solutions market, 2018 - 2030 (USD Million)
      • 8.4.1.5 Spain
      • 8.4.1.5.1 Spain Real world Evidence Solutions market, 2018 - 2030 (USD Million)
  • 8.5 Asia Pacific
    • 8.5.1 Asia Pacific Real world Evidence Solutions market, 2018 - 2030 (USD Million)
      • 8.5.1.1 Japan
      • 8.5.1.1.1Japan Real world Evidence Solutions market, 2018 - 2030 (USD Million)
      • 8.5.1.2 China
      • 8.5.1.2.1China Real world Evidence Solutions market, 2018 - 2030 (USD Million)
      • 8.5.1.3 India
      • 8.5.1.3.1India Real world Evidence Solutions market, 2018 - 2030 (USD Million)
      • 8.5.1.4 Australia
      • 8.5.1.4.1Australia Real world Evidence Solutions market, 2018 - 2030 (USD Million)
      • 8.5.1.5 South Korea
      • 8.5.1.5.1 South Korea Real world Evidence Solutions market, 2018 - 2030 (USD Million)
  • 8.6. Latin America
    • 8.6.1 Latin America Real world Evidence Solutions market, 2018 - 2030 (USD Million)
      • 8.6.1.1 Brazil
      • 8.6.1.1.1 Brazil Real world Evidence Solutions market, 2018 - 2030 (USD Million)
      • 8.6.1.2 Mexico
      • 8.6.1.2.1 Mexico Real world Evidence Solutions market, 2018 - 2030 (USD Million)
      • 8.6.1.3 Argentina
      • 8.6.1.3.1 Argentina Real world Evidence Solutions market, 2018 - 2030 (USD Million)
  • 8.7 MEA
    • 8.7.1 MEA Real world Evidence Solutions market, 2018 - 2030 (USD Million)
      • 8.7.1.1 South Africa
      • 8.7.1.1.1South Africa Real world Evidence Solutions market, 2018 - 2030 (USD Million)
      • 8.7.1.2 Saudi Arabia
      • 8.7.1.2.1 Saudi Arabia Real world Evidence Solutions market, 2018 - 2030 (USD Million)
      • 8.7.1.3 Israel
      • 8.7.1.3.1 Israel Real world Evidence Solutions market, 2018 - 2030 (USD Million)

Chapter 9 Real world Evidence Solutions Market: Competitive Analysis

  • 9.1 Company Market Share/Position Analysis
  • 9.2 Heat Map Analysis
  • 9.3 List of Key Companies

Chapter 10 Company Profiles

  • 10.1 IQVIA
    • 10.1.1 Company Overview
    • 10.1.2 Financial Performance
    • 10.1.3 Product Benchmarking
    • 10.1.4 Strategic Initiatives
  • 10.2 IBM
    • 10.2.1 Company Overview
    • 10.2.2 Financial Performance
    • 10.2.3 Product Benchmarking
    • 10.2.4 Strategic Initiatives
  • 10.3 PPD Inc.
    • 10.3.1 Company Overview
    • 10.3.2 Financial Performance
    • 10.3.3 Product Benchmarking
    • 10.3.4 Strategic Initiatives
  • 10.4 Parexel International Corporation
    • 10.4.1 Company Overview
    • 10.4.2 Financial Performance
    • 10.4.3 Product Benchmarking
    • 10.4.4 Strategic Initiatives
  • 10.5 PerkinElmer Inc.
    • 10.5.1 Company Overview
    • 10.5.2 Financial Performance
    • 10.5.3 Product Benchmarking
    • 10.5.4 Strategic Initiatives
  • 10.6 Icon Plc
    • 10.6.1 Company Overview
    • 10.6.2 Financial Performance
    • 10.6.3 Product Benchmarking
    • 10.6.4 Strategic Initiatives
  • 10.7 Oracle
    • 10.7.1 Company Overview
    • 10.7.2 Financial Performance
    • 10.7.3 Product Benchmarking
    • 10.7.4 Strategic Initiatives
  • 10.8 Syneos Health
    • 10.8.1 Company Overview
    • 10.8.2 Financial Performance
    • 10.8.3 Product Benchmarking
    • 10.8.4 Strategic Initiatives
  • 10.9 Cegedim Health Data
    • 10.9.1 Company Overview
    • 10.9.2 Financial Performance
    • 10.9.3 Product Benchmarking
    • 10.9.4 Strategic Initiatives
  • 10.10 Medpace
    • 10.10.1 Company Overview
    • 10.10.2 Financial Performance
    • 10.10.3 Product Benchmarking
    • 10.10.4 Strategic Initiatives